Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study

Tkachev A.V.; Tarasova G.N.; Groshilin V.S.; Vasilchenkov D.A.; Ushakova T.I.; Blinov D.V.

doi:https://doi.org/10.17116/terarkh201688859-66

Tkachev A.V.

Rostov State Medical University, Ministry of Health of Russia, Rostov-on-Don, Russia

Tarasova G.N.

Rostov State Medical University, Ministry of Health of Russia, Rostov-on-Don, Russia

Groshilin V.S.

Rostov State Medical University, Health Ministry of the Russia, Rostov-on-Don, Russia

Vasilchenkov D.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Ushakova T.I.

OOO «KM Praktika», Moscow, Russia

Blinov D.V.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study

Authors:

Tkachev A.V., Tarasova G.N., Groshilin V.S., Vasilchenkov D.A., Ushakova T.I., Blinov D.V.

More about the authors

Journal: Therapeutic Archive. 2016;88(8): 59‑66

DOI: 10.17116/terarkh201688859-66

Read: 2332 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Tkachev AV, Tarasova GN, Groshilin VS, Vasilchenkov DA, Ushakova TI, Blinov DV. Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study. Therapeutic Archive. 2016;88(8):59‑66. (In Russ.)
https://doi.org/10.17116/terarkh201688859-66

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Population models for the general and primary incidence of borderline mental disorders in the Russian Federation in 1992—2022. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):113-121

Gastrointestinal stromal tumors of the esophagus in adults: a systematic review. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):5-28

Retrospective analysis of sexually transmitted infections incidence in countries of the world. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):132-142

Epidemiology of M. genitalium infection. What is known?. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):143-152

The condition of bone tissue in patients with non-alcoholic fatty liver disease. Russian Journal of Preventive Medicine. 2025;(5):82-89

Prevalence and characteristics of risk factors for cerebrovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124

Prevalence of postpartum depression in the Russian Federation: a systematic review and meta-analysis. Medical Technologies. Assessment and Choice. 2025;(2):74-87

Prevalence of chronic pain in adult population of the Russian Federation: an all-Russian epidemiological study. Russian Journal of Pain. 2025;(2):54-62

Sarcopenia index for detecting of the decreased muscle strength and mass in patients with the non-alcoholic fatty liver disease. Russian Journal of Preventive Medicine. 2025;(7):68-74

Epidemiology and prevention of prostate cancer. Russian Journal of Preventive Medicine. 2025;(7):111-118

Abstract:

Aim. To analyze and summarize the data of the DIREG-2 study of the nonalcoholic fatty liver disease (NAFLD) register in Rostov-on-Don versus those in Russia. Materials and methods. The prospective disease registry study encompasses an epidemiologic, observational, cross-sectional, multicenter study estimating the prevalence of NAFLD in outpatients in Rostov-on-Don. A total of 3200 patients participated in this study. The investigators were 65 outpatient physicians. Epidemiological data were obtained during two patient visits to the research centers. Results. The key result obtained from this study was the significantly higher prevalence of NAFLD in Rostov-on-Don than that in the general population (40.4 and 37.3%). In addition to the higher prevalence of NAFLD, there was also a higher spread of risk factors (RFs), such as abdominal obesity, female age of 45-55 years, and hyperlipidemia. Conclusion. The prevalence of NAFLD in the outpatients of Rostov-on-Don was 3.1% greater than that in Russia; this might be due to the significantly higher spread of some RFs (abdominal obesity, female age of 45-55 years, hyperlipidemia). The findings are undoubtedly necessary for the elaboration of measures for the primary and secondary prevention of NAFLD in Rostov-on-Don.

Keywords:

DIREG-2 study

epidemiology

non-alcoholic fatty liver disease

nonalcoholic steatohepatitis

prevalence

Rostov-on-Don

Authors:

Tkachev A.V.

Rostov State Medical University, Ministry of Health of Russia, Rostov-on-Don, Russia

Tarasova G.N.

Rostov State Medical University, Ministry of Health of Russia, Rostov-on-Don, Russia

Groshilin V.S.

Rostov State Medical University, Health Ministry of the Russia, Rostov-on-Don, Russia

Vasilchenkov D.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Ushakova T.I.

OOO «KM Praktika», Moscow, Russia

Blinov D.V.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Close metadata

References:

Podymova S. The evolution of ideas about non-alcoholic fatty liver disease. Eksperimental'naya i klinicheskaya gastroenterologiya. 2009;4:4-12. (In Russ.)
LaBrecque et al. World Gastroenterology Organisation Global GuidelinesNonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. J Clin Gastroenterol. 2014;48(6):467-473. doi:10.1097/mcg.0000000000000116
Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol. 2014;28(4):637-653. doi:10.1016/j.bpg.2014.07.008
Ivashkin V, Drapkina O, Maev I, Troukhmanov A, Blinov D, Palgova L, Ushakova T. Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results. RZhGGK. 2015;6:31-41. (In Russ.)
Tsukanov V, Tonkikh Yu, Kasparov E i dr. Nonalcoholic fatty liver disease in an adult urban population of Russia (prevalence and risk factors). Vrach. 2010;9:2-6. (In Russ.)
Verdelho Machado M, Cortez-Pinto H. Fatty liver in lean patients: is it a different disease? Annals of Gastroenterology. 2012;25(1):1-2.
Smetnik V. Premature menopause. Lechashchii vrach. 2004;10:8-12. (In Russ.)
Ryu S, Suh B-S, Chang Y, Kwon M-J, Yun KE, Jung H-S, Cho J. Menopausal stages and non-alcoholic fatty liver disease in middle-aged women. Eur J Obstet Gynecol Reprod Biol. 2015;190:65-70. doi:10.1016/j.ejogrb.2015.04.017
Statcenko M, Tyrkina S, Lempert B, Bakymov P. Nonalcoholic fatty liver disease: risk marker or pathogenetic factor for cardiovascular diseases? Vestnik VolgGMU. 2012;1(4):10-14. (In Russ.)
De Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48(suppl 1):104-112. doi:10.1016/j.jhep.2008.01.009
Blinov D. Non-alcoholic fatty liver disease outcomes funnel. pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiology. 2015;8(3):14-19. (In Russ.)
Kucheryavy Yu, Stukova N, Ahtayeva M. Chronic hepatitis, liver cirrhosis and hepatocellular carcinoma - links in one and the same chain. Klinicheskie perspektivy gastroenterologii, gepatologii. 2012;5:3-11. (In Russ.)
Takuma Y. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: Our case series and literature review. WJG. 2010;16(12):1436. doi:10.3748/wjg.v16.i12.1436
Yaroshenko E, Burnevich E, Moisyuk Ya. The role of viral hepatitis in the development of hepatocellular carcinoma. Prakticheskaya onkologiya. 2008;9(4):189-193. (In Russ.)
Gomaa AI, Khan SA, Toledano MB et al. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. Wld J Gastroenterol. 2008;14(27):4300-4308. doi:10.3748/wjg.14.4300
Mazzanti R, Gramantieri L, Bolondi L. Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Asp Med. 2008;29(1-2):130-143. doi:10.1016/j.mam.2007.09.008
Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol. 2009;3(4):353-367. doi:10.1586/egh.09.35
Waly Raphael S, Yangde Z, Yuxiang C. Hepatocellular Carcinoma: Focus on Different Aspects of Management. ISRN Oncology. 2012;1-12. doi:10.5402/2012/421673
Babak O., Causes and metabolic consequences of nonalcoholic fatty liver disease. Suchasna gastroenterologіya. 2010;54(4):8-16. (In Russ.)
Choi SY, Kim D, Kang JH, Park MJ, Kim YS, Lim SH, Kim CH, Lee HS. Nonalcoholic fatty Liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty Liver disease to carotid atherosclerosis. The Korean Journal of Hepatology. 2008;14(1):77-88. doi:10.3350/kjhep.2008.14.1.77
Picardi A, Vespasiani-Gentilucci U. Association Between Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A First Message Should Pass. The American Journal of Gastroenterology. 2008;103(12):3036-3038. doi:10.1111/j.1572-0241.2008.02196.x
The Demographic Yearbook of Russia. 2015: Statistical Handbook Rosstat. Moscow; 2015. (In Russ.)
Drapkina O, Korneeva O. Nonalcoholic fatty liver disease and cardiovascular risk: influence of female sex. Farmateka. 2010;209(15):28-33. (In Russ.)
Ivashkin V. Rossiiskoe obshchestvo po izucheniyu pecheni. Diagnostika i lechenie nealkogol'noi zhirovoi bolezni pecheni. Metodicheskie rekomendatsii dlya vrachei. Moscow; 2015. (In Russ.)
Gundermann KJ, Kuenker A, Kuntz E, Droździk M. Activity of essential phospholipids (EPL) from soybean in liver diseases. Pharmacol Rep. 2011;63:643-659. doi:10.1016/s1734-1140(11)70576-x
Blinov D, Zimovina U, Ushakova T. Pharmacoepidemiological evaluation of hepatotropic therapy in real clinical practice, farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2015;1:31-38. (In Russ.)
Sas E, Grinevich V, Efimov O, Shcherbina N. 1366 Beneficial influence of polyunsaturated phosphatidylcholine enhances functional liver condition and liver structure in patients with nonalcoholic steatohepatitis. results of prolonged randomized blinded prospective clinical study. Journal of Hepatology. 2013;58:549. doi:10.1016/s0168-8278(13)61365-3
Dajani AIM, Hammour AMA, Zakaria MA, Al Jaberi MR, Nounou MA, Semrin AIM, Essential phospholipids as a supportive adjunct in the management of patients with NAFLD. Arab Journal of Gastroenterology. 2015;16:99-104. doi:10.1016/j.ajg.2015.09.001
Akusherstvo. Natsional'noe rukovodstvo. Pod red. Savel'evoi G, Sukhikh G, Serova V, Radzinskogo V. Moscow: Geotar; 2015. (In Russ.)
Lazebnik L, Radchenko V, Golovanova E, Zvenigorodskaya L, Konev Yu, Seliverstov P, Sitkin S, Tkachenko E, Ailamazyan E, Vlasov N, Kornienko E, Novikova V, Khoroshinina L, Zhestkova N, Oreshko L, Dudanova O, Dobritsa V, Tur'eva L, Tirikova O, Kozlova N, Eliseev S, Gumerov R, Ventsak E. Nealkogol'naya zhirovaya bolezn' pecheni: klinika, diagnostika, lechenie. Rekomendatsii dlya terapevtov. Utverzhdeny s"ezdom Nauchnogo obshchestva gastroenterologov Rossii (NOGR) 27.05.2015. (In Russ.)
Ignat'eva V, Avksent'eva M. The analysis of methodologic characteristics of researches on social and economic burden of diseases in Russia in the frames of development of standard cost of illness methodology for the health technology assessment farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2014;3:3-11. (In Russ.)
Polivanov V. Pharmacoeconomic analysis of therapy of alcoholic illness of the liver in steatoz stage and the hepatites essliver forte and Essentiale forte H. Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2009;1:7-11. (In Russ.)
Sas E, Blinov D, Zimovina U. Features of patients treated by essential phospholipids at real life conditions. Klinicheskie perspektivy gastroenterologii, gepatologii. 2015;1:9-17. (In Russ.)
Lipatova L. Neuro-immune mechanism of epilepsy as a key to pathogenetic treatment of the disease. Epilepsiya i paroksizmal'nye sostoyaniya. 2010;3:20-27. (In Russ.)
Makarov I, Borovkova E, Kazakov R. Prevalence of non-alcoholic fatty liver disease among obese pregnant women. Akusherstvo, ginekologiya i reproduktsiya. 2012;4:18-21.
Makarov I, Pavlov Ch, Shemanaeva T, Voevodin S, Muravei A. The modern view on the problem of treatment of chronic hepatitis during pregnancy. Akusherstvo, ginekologiya i reproduktsiya. 2013;1:22-25. (In Russ.)